Results confirmed that kaempferol could promote apoptosis of LNCaP (androgen-sensitive human prostate adenocarcinoma cells), AR-positive prostate cancer cells, in a dose-dependent manner. This evidence concerns the gene AR and prostate adenocarcinoma.